Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-10-04
1999-08-03
Davenport, Avis M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514 13, 514 15, 530323, 530324, 530325, 530326, 530327, 530328, A61K 3800, A61K 3802, C07K 500, C07K 700
Patent
active
059325461
ABSTRACT:
Described are peptides and peptide mimetics that bind to and activate the thrombopoietin receptor. Such peptides and peptide mimetics are useful in methods for treating hematological disorders and particularly, thrombocytopenia resulting from chemotherapy, radiation therapy, or bone marrow transfusions as well as in diagnostic methods employing labeled peptides and peptide mimetics.
REFERENCES:
patent: 5143854 (1992-09-01), Pirrung et al.
patent: 5270170 (1993-12-01), Schatz et al.
patent: 5338665 (1994-08-01), Schatz et al.
patent: 5424186 (1995-06-01), Fodor et al.
patent: 5432018 (1995-07-01), Dower et al.
patent: 5489678 (1996-02-01), Fodor et al.
patent: 5503805 (1996-04-01), Sugarman et al.
patent: 5527681 (1996-06-01), Holmes
patent: 5608035 (1997-03-01), Barrett et al.
patent: 5639603 (1997-06-01), Dower et al.
patent: 5665975 (1997-09-01), Kedar
patent: 5708153 (1998-01-01), Dower et al.
patent: 5723286 (1998-03-01), Dower et al.
McDonald, American Journal Pediatric Hematology/Oncology, 14, 1992, pp. 8-21, "Thrombopoietin, Its Biology, Clinical Aspects, and Possibilities".
Barley, et al., Cell, 77, 1994, pp. 1117-1124, "Identification and Cloning of a Megakaryocyte Growth and Development Factor That Is a Ligand for the Cytokine Receptor MpI".
Kaushansky, et al., Nature, 369, 1994, pp. 568-571, "Promotion of Megakaryocyte Progenitor Expansion and Differentiation by the c-Mpl Ligand Thrombopoietin".
Wendling, et al., Nature, 369, 1994, pp. 571-574, "c-MpI Ligand is a Humoral Regulator of Megakaryocytopoiesis".
Sauvage et al., Nature, 369, 1994, pp. 533-538, "Stimulation of Megakaryocytopoiesis and Thrombopoiesis by the c-Mpl Ligand".
Vigon, et al., Proc. Natl. Acad. Sci. USA, 89, 1992, pp. 5640-5644, "Molecular Cloning and Characterization of MPL, the Human Homolog of the v-mpl Oncogene: Identification of a Member of the Hematopoietic Growth Factor Receptor Superfamily".
Bazan, Proc. Natl. Acad. Sci. USA, 87, 1990, pp. 6934-6938, "Structural Design and Molecular Evolution of a Cytokine Receptor Superfamily".
Souyri, et al., Cell, 63, 1990, pp. 1137-1147, "A Putative Truncated Cytokine Receptor Gene Transduced by the Myeloproliferative Leukemia Virus Immortalizes Hematopoietic Progenitors".
Methia, et al., Blood, 82, 1993, pp. 1395-1401, "Oligodeoxynucleotides Antisense to the Proto-Oncogene c-mpl Specifically Inhibit In Vitro Megakaryocytopoiesis".
Cwirla, et al., Proc. Natl. Acad. Sci. USA, 87, 1990, pp. 6378-6382, "Peptides on Phage: A Vast Library of Peptides for Identifying Ligands".
Fodor, et al., Science, 251, 1991, pp. 767-773, "Light-Directed, Spatially Addressable Parallel Chemical Synthesis".
Dower and Fodor, Ann. Rep. Med. Chem., 26, 1991, pp. 271-280, "Chapter 28: The Search for Molecular Diversity (II): Recombinant and Synthetic Randomized Peptide Libraries".
Kuter, et al., Proc. Natl. Acad. Sci. USA, 91, 1994, pp. 11104-11108, "The Purification of Megapoietin: A Physiological Regulator of Megakaryocyte Growth and Platelet Production".
Harker, J. Clin. Invest., 47, 1968, pp. 458-465, "Kinetics of Thrombopoiesis".
Metcalf, Nature, 369, 1994, pp. 519-520, "Thrombopoietin -at Last".
Barrett Ronald W.
Cwirla Steven E.
Dower William J.
Duffin David J.
Johnson Sherril S.
Davenport Avis M.
Glaxo Wellcome Inc.
Hrubiec Robert T.
Stevens Lauren L.
LandOfFree
Peptides and compounds that bind to the thrombopoietin receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides and compounds that bind to the thrombopoietin receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides and compounds that bind to the thrombopoietin receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-849459